GLP-1 medications, like Ozempic and Wegovy, mimic natural hormones in the body that regulate blood sugar and insulin levels. They’re used to treat type 2 diabetes and obesity. These drugs curb the ...

UBS Group began coverage on shares of Altimmune (NASDAQ:ALT – Free Report) in a research note issued to investors on Tuesday, Marketbeat reports. The firm issued a buy rating and a $26.00 target price ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...

Good afternoon, and welcome to Fractyl Health's Third Quarter Financial Results and Business Updates Call. As a reminder, this conference call is being recorded. [Operator Instructions]. I will now ...

In a recent federal benefits survey, OPM found that 81% of respondents identified out-of-pocket costs as a top factor when selecting a health plan.

Nearly three quarters of U.S. adults are overweight or obese, according to a sweeping new study. The findings have ...

Over the past three decades, there has been a startling increase in the prevalence of obesity across the U.S., at least ...

DaVita’s strong services face risks from debt and economic uncertainties. Find out why DVA stock is a "Hold" with a $130 ...

In an essay for 'Women's Health,' Dr. Nora Volkow discusses the future of semaglutide weight-loss meds, and their potential ...

A recent study that found there has been a massive increase in type 2 diabetes cases worldwide since 1990 is an indication ...

(Irwin, 11/13) Yahoo Finance: Hims & Hers Launches GLP-1 Tracker In Response To FDA's Shortage Decision ... Those plans were perhaps best summarized by Representative Matt Gaetz, who wrote of his ...